Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating tumor-infiltrating lymphocyte immunotherapy for patients with advanced hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tumor Infiltrating Lymphocytes (TIL) Immunotherapy (tumor-infiltrating lymphocytes)

Snippet

Sponsor: Zhiyong Huang | Conditions: Liver Cancer | Phase 1 | Status: RECRUITING